Thomas Hilliard, PA
Medical · Oregon City, ORNPI 1982196846
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (57.6%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Arthrex accounts for 66.8% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2021 at $3,621 and has fallen 98.1% since, to $68 in 2025. Among medical clinicians in OR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 22 payments — averaging $189.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$3K
- Steelhead Surgical Inc$820
- Biomerieux Inc$300
- Bioventus LLC$99
- Sanofi-aventis U.S. LLC$37
- DJO, LLC$31
- plus $95 from 5 others
What the payments were for
- Consulting fees$3007%
- Travel & lodging$1,10927%
- Food & beverage$3559%
- Education$2,40058%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 9 | $2,783 |
| Steelhead Surgical Inc | 2 | $820 |
| Biomerieux Inc | 1 | $300 |
| Bioventus LLC | 3 | $99 |
| Sanofi-aventis U.S. LLC | 1 | $37 |
| DJO, LLC | 1 | $31 |
| Ultragenyx Pharmaceutical Inc. | 1 | $22 |
| Ferring Pharmaceuticals Inc. | 1 | $21 |
| Pacira Pharmaceuticals Incorporated | 1 | $19 |
| Merck | 1 | $18 |
| Zimmer Biomet | 1 | $15 |
How this compares
$4,164 in reported general payments places this provider in the 95th percentile of 364 medical providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 183 | $1,213 |
| Tizanidine Hcl | 146 | $811 |
| Diclofenac Sodium | 29 | $580 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 50 | $320 |
| Ondansetron Hcl | 74 | $255 |
| Methylprednisolone | 24 | $178 |
| Ondansetron OdtOndansetron | 29 | $163 |
| Hydromorphone Hcl | 17 | $127 |
| Meloxicam | 26 | $69 |
| Cephalexin | 22 | $62 |
Paid to pharmacies, not to this prescriber.
Other medical in Oregon City
- Caitlyn BealsOregon City$5K
- Mark DavisLake Oswego$12K
- Britt BennPortland$11K
- Benjamin WillettSalem$11K
- Jeffrey RennaSalem$9K
- Christy SnoSpringfield$8K
- Erica BallardPortland$8K
- Nicole WydraCorvallis$8K
- Caitlyn EricksonHillsboro$6K
- Brolin JohnsonSalem$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.